The main threat of the new law is a significant reduction in the range of imported drugs in pharmacies, says Vitaly Kulik.
In Ukraine, a number of popular drugs may disappear from pharmacies due to the new regulation of the pharmaceutical market. After all, law No. 11493, adopted by Verkhovna Rada, creates unacceptable -accepted conditions for the work of international pharmaceutical companies and can make them leave the market. This opinion is pronounced by a political scientist, Director of the Civil Society Research Center Vitaly Kulik in his blog censor.
According to him, the main threat of the new law is a significant reduction in the range of drugs at Ukrainian pharmacies, especially those who are imported. The reason for this is the margin limit of shares and representatives of the representative up to 8%, making the work of international companies not noticeable.
“This will lead to companies such as Delta Medical, Berlin-Cheemie, Sakong, they will be forced to leave the Ukrainian market, the drugs will disappear from pharmacies, including patients in succession. Pharmaceuticals say there are no ones For example, well -known Ferex, Diprellis, Forteza, Posan, Nimesil, Dexalgin and many others will be lost, and many others will be lost, ”Kulik wrote.
He believes that the reference reference may force international manufacturers to raise prices by 40-50%. The reason is that pharmaceutical companies work according to a single global pricing system. If the price falls into a country, it will automatically check from everyone.
Earlier in Ukraine, the imported drugs were reduced due to marketing agreements in which manufacturers provided discounts on pharmacies. Now these transactions have been canceled, which means that the final price of the drugs will grow, and if the demand collapses, importers will leave the market.
Like Kulik’s notes, due to such changes, consecutive patients with illness, cancer patients, people with autoimmune illness are injured – because most of the imported drugs are used in those International treatment protocol. State social programs are also under the threat: if prices are rising, the budget does not have enough funds to provide patients with the necessary medications.
In addition, according to the expert, the proposed “price catalog”, which should adjust the cost of the drugs, still raises many questions. None of the market participants – shares, pharmaceutical companies, representatives – do not understand how this system will work in training.
“If the President signed the law and he insisted, Ukraine is waiting for a pharmaceutical crisis. We will get a lack of drugs, a sharp increase in prices and a reduction in quality of treatment,” Kulik believes.
At the same time, he is sure that the indicated changes are “submitted under a completely different sauce” to President Vladimir Zelensky.
“In an attempt to go around competitors in competition for deciding the” illness “of the authorities, they seem to be not considering the clear dangers. Under the leadership of Mikhail Radutsky has threatened the pharmaceutical market and directly affect In Ukrainians.
Remember, on February 5, President Vladimir Zelensky criticized the situation in the drug market and held a meeting of the National Security and Defense Council on this issue. One week later, the head of the Ukrainian state signed a command in additional steps to ensure the availability of drugs for the Ukrainians.
On February 14, the government has limited the maximum trading margin for pharmacies of no more than 35% for over -counters and set a regressive scale for the prescription. Suppliers can add no more than 8% to wholesale prices, depending on the cost of the drug.
Source: korrespondent
I’m Liza Grey, an experienced news writer and author at the Buna Times. I specialize in writing about economic issues, with a focus on uncovering stories that have a positive impact on society. With over seven years of experience in the news industry, I am highly knowledgeable about current events and the ways in which they affect our daily lives.